The Tulane team has developed a handful of other assays for TB detection, including a mass spec test for paucibacillary TB ...

The Tulane team has developed a handful of other assays for TB detection, including mass spec test for paucibacillary TB that is being commercialized by Nanopin Tech, and a non-sputum CRISPR-based lab ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

A letter to the US public on the AMA website, signed by 75+ medical societies, stresses the vital importance of influenza, ...

Frailty was a significant predictor of severe outcomes and hospitalization characteristics in older adults hospitalized with RSV infection.

COVID-19 transmission is still high in Pima County, with over 200 cases per 100,000 residents being reported; and eight-to-10 times more influenza cases are being reported across metro Tucson than ...

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...